AG
CNCE

Artal Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Artal Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-573,062
Closed -$3.84M – 139
2022
Q3 		$3.84M Buy
+573,062
New +$3.84M 0.16% 64